Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
Ulla Randen, Gunhild Trøen, Anne Tierens, et al.
Haematologica (2013) Vol. 99, Iss. 3, pp. 497-504
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elı́as Campo, Elaine S. Jaffe, James R. Cook, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1229-1253
Open Access | Times Cited: 954
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D’Sa, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 14, pp. 1323-1334
Open Access | Times Cited: 156
Autoimmune Hemolytic Anemias
Sigbjørn Berentsen, Wilma Barcellini
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1407-1419
Closed Access | Times Cited: 140
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120
Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment
Ryan M. Young, James D. Phelan, Wyndham H. Wilson, et al.
Immunological Reviews (2019) Vol. 291, Iss. 1, pp. 190-213
Open Access | Times Cited: 115
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
Sigbjørn Berentsen, Ulla Randen, Markku Oksman, et al.
Blood (2017) Vol. 130, Iss. 4, pp. 537-541
Open Access | Times Cited: 113
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
Steven H. Swerdlow, Işınsu Kuzu, Ahmet Doğan, et al.
Virchows Archiv (2015) Vol. 468, Iss. 3, pp. 259-275
Open Access | Times Cited: 108
Cold agglutinin disease
Sigbjørn Berentsen
Hematology (2016) Vol. 2016, Iss. 1, pp. 226-231
Open Access | Times Cited: 101
How I manage patients with cold agglutinin disease
Sigbjørn Berentsen
British Journal of Haematology (2018) Vol. 181, Iss. 3, pp. 320-330
Open Access | Times Cited: 98
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, et al.
Blood (2018) Vol. 133, Iss. 9, pp. 893-901
Open Access | Times Cited: 98
Complementopathies
Andrea C. Baines, Robert A. Brodsky
Blood Reviews (2017) Vol. 31, Iss. 4, pp. 213-223
Open Access | Times Cited: 98
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen, Ulla Randen, Geir E. Tjønnfjord
Hematology/Oncology Clinics of North America (2015) Vol. 29, Iss. 3, pp. 455-471
Closed Access | Times Cited: 97
MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity
J Schmidt, Birgit Federmann, Natalie Martina Schindler, et al.
British Journal of Haematology (2015) Vol. 169, Iss. 6, pp. 795-803
Open Access | Times Cited: 94
How I treat cold agglutinin disease
Sigbjørn Berentsen
Blood (2021) Vol. 137, Iss. 10, pp. 1295-1303
Open Access | Times Cited: 93
Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
Sigbjørn Berentsen, Tatjana Sundic
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 92
Complement in hemolytic anemia
Robert A. Brodsky
Blood (2015) Vol. 126, Iss. 22, pp. 2459-2465
Open Access | Times Cited: 91
Complementopathies and precision medicine
Eleni Gavriilaki, Robert A. Brodsky
Journal of Clinical Investigation (2020) Vol. 130, Iss. 5, pp. 2152-2163
Open Access | Times Cited: 90
Autoimmune hemolytic anemia: current knowledge and perspectives
Sylwia Sulimiera Michalak, Anna Olewicz‐Gawlik, Joanna Rupa‐Matysek, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88
IgM monoclonal gammopathies of clinical significance: diagnosis and management
Jahanzaib Khwaja, Shirley D’Sa, Monique C. Minnema, et al.
Haematologica (2022) Vol. 107, Iss. 9, pp. 2037-2050
Open Access | Times Cited: 48
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas
Brunangelo Falini, Giovanni Martino, Stefano Lazzi
Leukemia (2022) Vol. 37, Iss. 1, pp. 18-34
Open Access | Times Cited: 45
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria
Steven P. Treon, Alessandra Tedeschi, Jesús F. San Miguel, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 97-106
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top